Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

AngioDynamics Receives FDA IDE Approval For RELIEF Feasibility Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment For Benign Prostatic Hyperplasia CI Jun. 17 AngioDynamics Secures ...

AngioDynamics expects full-year results to range from a loss of 29 cents per share to a loss of 24 cents per share, with revenue in the range of $336 million to $341 million. AngioDynamics shares have ...

A Finnish cohort study of 644 older men with hip fracture found that pre-fracture fecal incontinence independently predicted one-year mortality, while urinary incontinence was strongly linked to ...

Bruce Arians shared his prostate cancer survival story during the NFL's "Crucial Catch" week, urging men to get a simple PSA ...

Emory University Hospital was recently selected as the first medical center to adopt the Liberty endovascular robotic system, developed by Microbot Medical and granted 510(k) clea ...

The financing is expected to accelerate commercialization of the Zenflow Spring System for benign prostatic hyperplasia ...

Cook Medical led the financing round, and signed up to exclusively distribute Zenflow's minimally invasive Spring implant.

Zenflow, Inc., developer of the Zenflow Spring® System, announced the close of an oversubscribed $52 million Series D financing round. The round was led by Cook Medical, with participation from new ...

The IDSA's first-ever complicated UTI guideline redefines the condition around systemic risk factors and severity, reflecting two decades of shifting resistance patterns, expanding indications, and ...